The Prague Post - US tycoon opens Africa's first start-to-finish Covid-19 jab plant

EUR -
AED 4.303976
AFN 81.441964
ALL 97.724417
AMD 449.756269
ANG 2.097062
AOA 1074.532108
ARS 1467.319002
AUD 1.793664
AWG 2.109223
AZN 2.007504
BAM 1.958274
BBD 2.365789
BDT 142.830437
BGN 1.955834
BHD 0.441678
BIF 3446.235331
BMD 1.17179
BND 1.500996
BOB 8.096228
BRL 6.556157
BSD 1.171981
BTN 100.360786
BWP 15.654777
BYN 3.834544
BYR 22967.090269
BZD 2.353573
CAD 1.604592
CDF 3381.786877
CHF 0.93107
CLF 0.029006
CLP 1113.110977
CNY 8.413747
CNH 8.416905
COP 4712.940666
CRC 590.946541
CUC 1.17179
CUP 31.052443
CVE 110.733745
CZK 24.628631
DJF 208.250341
DKK 7.46078
DOP 70.48331
DZD 152.044871
EGP 58.118102
ERN 17.576855
ETB 159.490077
FJD 2.633306
FKP 0.863336
GBP 0.862264
GEL 3.175215
GGP 0.863336
GHS 12.176313
GIP 0.863336
GMD 83.782479
GNF 10143.017355
GTQ 9.005376
GYD 245.029545
HKD 9.197904
HNL 30.876537
HRK 7.532502
HTG 153.784275
HUF 399.797296
IDR 19039.249117
ILS 3.888528
IMP 0.863336
INR 100.455709
IQD 1535.045319
IRR 49361.666877
ISK 143.40402
JEP 0.863336
JMD 187.306624
JOD 0.830825
JPY 171.514723
KES 151.742248
KGS 102.473037
KHR 4711.768848
KMF 493.324088
KPW 1054.585525
KRW 1610.122236
KWD 0.357783
KYD 0.976434
KZT 607.637627
LAK 25240.363919
LBP 104992.412278
LKR 352.255003
LRD 234.941473
LSL 20.846005
LTL 3.459992
LVL 0.708804
LYD 6.329253
MAD 10.551939
MDL 19.860089
MGA 5191.031139
MKD 61.507957
MMK 2460.182431
MNT 4205.038884
MOP 9.474069
MRU 46.525908
MUR 52.972553
MVR 18.042664
MWK 2034.81537
MXN 21.838129
MYR 4.980692
MZN 74.947358
NAD 20.845642
NGN 1797.127848
NIO 43.063088
NOK 11.836558
NPR 160.576856
NZD 1.952268
OMR 0.450555
PAB 1.17168
PEN 4.153409
PGK 4.848848
PHP 66.335527
PKR 333.081322
PLN 4.246852
PYG 9081.472602
QAR 4.266021
RON 5.077134
RSD 117.19662
RUB 91.646306
RWF 1680.347319
SAR 4.395227
SBD 9.769127
SCR 16.535124
SDG 703.660427
SEK 11.142801
SGD 1.50036
SHP 0.920843
SLE 26.368938
SLL 24571.861406
SOS 669.677436
SRD 43.649776
STD 24253.693785
SVC 10.251951
SYP 15235.769903
SZL 20.846096
THB 38.293909
TJS 11.336221
TMT 4.112984
TND 3.40394
TOP 2.744453
TRY 46.921414
TTD 7.956051
TWD 34.240841
TZS 3078.883475
UAH 48.97497
UGX 4206.313826
USD 1.17179
UYU 47.39988
UZS 14875.878317
VES 131.577763
VND 30629.42717
VUV 139.799183
WST 3.226363
XAF 656.786717
XAG 0.032209
XAU 0.000354
XCD 3.166822
XDR 0.815664
XOF 654.420316
XPF 119.331742
YER 283.397416
ZAR 20.8927
ZMK 10547.504558
ZMW 28.502007
ZWL 377.316005
  • CMSC

    0.0900

    22.314

    +0.4%

  • CMSD

    0.0250

    22.285

    +0.11%

  • RBGPF

    0.0000

    69.04

    0%

  • SCS

    0.0400

    10.74

    +0.37%

  • RELX

    0.0300

    53

    +0.06%

  • RIO

    -0.1400

    59.33

    -0.24%

  • GSK

    0.1300

    41.45

    +0.31%

  • NGG

    0.2700

    71.48

    +0.38%

  • BP

    0.1750

    30.4

    +0.58%

  • BTI

    0.7150

    48.215

    +1.48%

  • BCC

    0.7900

    91.02

    +0.87%

  • JRI

    0.0200

    13.13

    +0.15%

  • VOD

    0.0100

    9.85

    +0.1%

  • BCE

    -0.0600

    22.445

    -0.27%

  • RYCEF

    0.1000

    12

    +0.83%

  • AZN

    -0.1200

    73.71

    -0.16%

US tycoon opens Africa's first start-to-finish Covid-19 jab plant

US tycoon opens Africa's first start-to-finish Covid-19 jab plant

US biotech billionaire Patrick Soon-Shiong on Wednesday opened a plant in Cape Town that will be the first in Africa to produce Covid-19 vaccines from start to finish.

Text size:

The factory should churn out its first vials of second-generation coronavirus vaccine "within the year" and produce a billion doses annually by 2025, Soon-Shiong said.

The plant will be South Africa's third Covid vaccine-manufacturing facility but the first in the continent to make the formula across every stage, rather than producing it from semi-finished batches.

With just 10.9 percent of the 1.3 billion people fully vaccinated, Africa is the least vaccinated continent in the world. This compares with approximately 63 percent in the US and around 70 percent in Europe.

Africa currently manufactures less than one percent of all vaccines administered on the continent, according to the World Health Organization (WHO).

South African President Cyril Ramaphosa, speaking at the inaugural event, hailed the plant as a sign of African self-reliance.

"Africa should no longer be the last in line to access vaccines against pandemics, Africa should no longer go cap in hand to the Western world begging and begging for vaccines," Ramaphosa said.

"We will stand on our own," he vowed, "without the shackles of colonial thinking."

He thanked Soon-Shiong, a South African-born and now United States-based doctor-turned-entrepreneur -- for returning "home" to invest in vaccine production.

Born in South Africa to Chinese parents and now a US citizen, the billionaire said the launch was "one of the momentous moments of my life -- this is a homecoming."

- T-cell vaccine -

After making a fortune by inventing a cancer drug, he founded NantWorks, a California-based startup in healthcare, biotech and artificial intelligence, in 2007.

Production at the state-of-the-art vaccine-manufacturing campus in Cape Town's Brackengate industrial area will be a collaborative effort between NantWorks, South African research institutions and four local universities.

"We have now developed this SN (spike nucleic) T-cell vaccine, a second-generation vaccine, and we want to manufacture this in Africa, for Africa, and export it to the world," Soon-Shiong said.

The vaccine is being developed "all the way from scratch", with self-amplifying RNA (ribonucleic acid) drug substance, to "full finish", the doctor said.

Johnson & Johnson has an operational "fill-and-finish" plant in South Africa, and Pfizer/BioNTech have partnered with Biovac to bottle their mRNA vaccine starting this year.

"We want to migrate from just doing 'fill and finish', to wanting to manufacture the drug substance ourselves," Ramaphosa said.

Meantime, a South African biotech consortium is working on a pilot project to tweak Moderna's mRNA formula, and prototype shots could be available for trial this year.

South Africa and India have been lobbying the World Trade Organization to temporarily suspend intellectual property rights so that Covid-19 vaccines are accessible to poorer countries.

The billionaire's family foundation, along with the Rockefeller Foundation, the US National Institutes of Health, the European Commission and the Bill & Melinda Gates Foundation, have raised more than one billion rand ($65 million, 57 million euros) to fund the project.

Soon-Shiong says that another $195 million will need to be raised to develop the new plant, which will also produce cancer vaccines.

The NantWorks project will also work on cell-based immunotherapies that could lead to new cancer vaccines and treatments.

N.Simek--TPP